Author:

Vandewoude KH, Vogelaers D

Date: 9 January 2007

Abstract:

Editorial; no abstract. Opening words: Reliable and timely diagnosis of invasive pulmonary aspergillosis (IPA) remains an interesting clinical challenge. At present, the in vivo clinical diagnosis of IPA is based on (1) host risk factors for the acquisition of this disease; (2) microbiological data, including the results of molecular diagnostic techniques; and (3) clinicoradiological data. The European Organization for Research and Treatment of Cancer/Mycoses Study Group incorporated these criteria into consensus diagnostic guidelines intended for clinical and epidemiological research involving patients with hematological malignancies or stem cell transplants.

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.

I understand (click to accept and view download link)

---